Placental Site Trophoblastic Tumour – A Rare Cause of Uncontrollable Post-Operative Hemorrhage in Obstetric Cases
Abstract
Placental site trophoblastic tumour (PSTT) is a rare variant of gestational trophoblastic disease developing from intermediate trophoblasts. PSTTs are incredibly rare tumours with 1 in 100000 pregnancies and only about 200 cases reported till date with mortality reaching up to 25% in undiagnosed cases. We present the case of a 37year old female, gravida 4 para 3, presenting with uncontrollable post caesarean haemorrhage for which she underwent subtotal hysterectomy. Histopathological examination revealed Placental site trophoblastic tumour. Placental site trophoblastic tumour, being a rare entity, pose difficulties in its early diagnosis. Delayed diagnosis can lead to distant metastases, thus worsening the prognosis.
Downloads
References
2. Scully RE & Young RH. Trophoblastic pseudotumor: a reappraisal. Am J Surg Pathol. 1981;5(1):75-6.
3. Zeng X, Liu X, Tian Q, Xue Y, An R. Placental site trophoblastic tumor: A case report and literature review. Intractable Rare Dis Res. 2015;4(3):147-151.
4. Bouquet de la Jolinière J, Khomsi F, Fadhlaoui A, Ben Ali N, Dubuisson JB, Feki A. Placental site trophoblastic tumor: a case report and review of the literature. Front Surg. 2014;1:31.
5. Kaur B. Pathology of gestational trophoblastic disease (GTD). Best Pract Res Clin Obstet Gynaecol. 2021;74:3-28.
6. Valzacchi GM, Odetto D, Chacon CB, Wernicke A, Xiang Y. Placental site trophoblastic disease. Int J Gynecol Cancer. 2020;30(1):144-9.
7. Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, et al. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol. 2007;20(10):1055-60.
8. Hui P, Parkash V, Perkins AS, Carcangiu ML. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Invest. 2000;80(6):965-72.
9. Lee HJ, Shin W, Jang YJ, Choi CH, Lee JW, Bae DS, et al. Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea. Obstet Gynecol Sci. 2018;61(3):319-27
10. Young, R., Scully, R., Mccluskey, R.A. Distinctive Glomerular Lesion Complicating Placental Site Trophoblastic Tumour: Report of Two Cases. Hum.Pathol. 1985;16:35-42.
11. Lan C, Li Y, He J, Liu J. Placental site trophoblastic tumor: lymphatic spread and possible target markers. Gynecol Oncol.2010;116:430–7.
12. Shih IM & Kurman RJ. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004;28(9):1177-83.
13. Shih IM & Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol. 1998;29(1):27-33.
14. Shih IM & Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22(11):1393-403.
15. Gari, A. Placental site trophoblastic tumor and choriocarcinoma: an unusual presentation. BMC Res Notes. 2015;8(1):1-4.
16. Alexander AL, Strohl AE, Maniar KP, Lurain JR. Placental site trophoblastic tumor: successful treatment of 13 cases. Gynecol Oncol Rep. 2020;32:100548.
Copyright (c) 2022 Bushra Siddiqui, Dipanjan Sinha , Shahbaz Habib Faridi, Mohd. Feroz Alam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
2.png)
International Archives of BioMedical and Clinical Research (IABCR)
